Seeking Category-Defining Businesses in High-Growth Markets
Experienced investors. Proven operators. Public market expertise.
Experienced investors. Proven operators. Public market expertise.
Cambridge Acquisition Corp. (NASDAQ: CAQ) is a special purpose acquisition company seeking businesses positioned to benefit from regulatory, technological and consumer-driven market shifts.
Our team combines private equity, venture capital, operational leadership, and public market experience to identify and support category-defining businesses.

Businesses with differentiated products, services or intellectual property that create barriers to entry and sustainable market leadership.

Companies positioned to capture significant market share in expanding sectors, with scalable business models and attractive margins.

Leadership with a demonstrated ability to execute, adapt, and innovate, and who can benefit from our strategic, operational and capital markets expertise.

Opportunities where our due diligence shows compelling value compared to public and private market peers.

Targets that can leverage public market access for growth capital, acquisition currency and enhanced brand credibility.




Christopher Bradley is a Managing Director at Mistral Equity Partners with two decades of experience in acquisitions and SPAC leadership. He has led or supported public combinations including OneSpaWorld, ARKO, Biote, and Suncrete, and holds board roles at Insomnia Cookies and multiple SPACs and private funds. Prior roles include investme
Christopher Bradley is a Managing Director at Mistral Equity Partners with two decades of experience in acquisitions and SPAC leadership. He has led or supported public combinations including OneSpaWorld, ARKO, Biote, and Suncrete, and holds board roles at Insomnia Cookies and multiple SPACs and private funds. Prior roles include investment banking at Bank of America and strategy at Burger King and PwC.

Vanessa Giannis is the founder of Convivium Advisors and a former CFO at Big Health and Tempus AI. With nearly 30 years of financial leadership experience, she has held senior roles across tech, health, and media companies. She holds degrees from the University of Notre Dame and Northwestern’s Kellogg School.

Eric Sklar is the founder and CEO of Napa Valley Fume and a longtime consumer packaged goods entrepreneur. He also serves as a Commissioner on the California Fish & Game Commission. His past ventures include founding and managing Burrito Brothers, Alpha Omega Winery, Yount Ridge Cellars, and Preslar Ventures. He previously served as both
Eric Sklar is the founder and CEO of Napa Valley Fume and a longtime consumer packaged goods entrepreneur. He also serves as a Commissioner on the California Fish & Game Commission. His past ventures include founding and managing Burrito Brothers, Alpha Omega Winery, Yount Ridge Cellars, and Preslar Ventures. He previously served as both a Planning Commissioner and City Council Member in St. Helena, California. He holds a BA from UC Berkeley and graduate business degrees from The London School of Economics and Georgetown University.
Our principals have delivered significant returns over a decade by backing category leaders (by market share) in sectors overlooked or avoided by mainstream capital. Notable investments include JUUL, Compass Pathways, MindMed, Beckley Psytech and Mindbloom, each of which achieved significant value creation and, in several cases, public market listings.
We have experience in nicotine harm reduction, hemp-derived consumables, psychedelics, functional botanicals, gaming, the love economy and health-oriented markets. This ability includes navigating complex regulatory environments and anticipating inflection points in public perception and policy.
Our team has co-founded, seeded or been the first institutional investor in numerous category-defining companies. These relationships provide us with proprietary deal flow and the ability to engage with high-caliber management teams early in their growth trajectory.
Collectively, our principals have executed dozens of transactions, including mergers, acquisitions, roll-ups and public offerings. We bring institutional rigor to strategy development, capital allocation, and governance.
Members of our team have successfully raised substantial capital and guided companies through the transition to public markets. Additionally, Christopher Bradley, one of our director nominees, formed part of the leadership team that has consummated numerous SPAC business combinations.
We apply rigorous due diligence, sector expertise and institutional investment discipline to identify businesses aligned with our acquisition strategy.
Cambridge Acquisition Corp.
One Liberty Square, 13th FL
Boston, MA 02109
(617) 396 4911
This website contains “forward-looking statements.” Forward-looking statements may be identified by the use of words such as "anticipate", "believe", "expect", "estimate", "plan", "outlook", and "project" and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements include statements regarding business plans, objectives, expectations and intentions of Cambridge Acquisition Corp. (the “Company”). These statements are based on current expectations and beliefs, as well as a number of assumptions concerning future events. Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company’s control that could cause actual results to differ materially from the results discussed in the forward-looking statements. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made, and, unless required by law, the Company undertakes no obligation to update or revise the forward looking statements, whether as a result of new information, future events or otherwise.
The information on this website shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the proposed transaction. The information on this website shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of section 10 of the Securities Act of 1933, as amended.
© 2026 CAMBRIDGE ACQUISITION CORP. ALL RIGHTS RESERVED.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.